Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：84

作者：

Aebi, S. ^{[1
]}

Davidson, T. ^{[2
]}

Gruber, G. ^{[3
]}

Castiglione, M. ^{[4
]}

机构：

[1] Univ Hosp Bern, Dept Med Oncol, CH-3010 Bern, Switzerland

[2] Univ Hosp, Finsen Ctr, Copenhagen, Denmark

[3] Klin Hirslanden, Inst Radiat Therapy, Zurich, Switzerland

[4] Univ Geneva, RGT, Geneva, Switzerland

来源：

ANNALS OF ONCOLOGY | 2010年 / 21卷

关键词：

INDUCED BONE LOSS; ZOLEDRONIC ACID; ADJUVANT CHEMOTHERAPY; PREMENOPAUSAL WOMEN; ENDOCRINE THERAPY; RECONSTRUCTION; TRASTUZUMAB; MASTECTOMY; TAMOXIFEN; CONSENSUS;

D O I：

10.1093/annonc/mdq159

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：v9 / v14

页数：6

共 26 条

[1]

Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0

[2]

Surgical guidelines for the management of breast cancer Association of Breast Surgery at BASO 2009 [J].

不详 .

EJSO, 2009, 35 :S1-S22

[3]

Bentzen SM, 2008, LANCET, V371, P1098, DOI 10.1016/S0140-6736(08)60348-7

[4]

The requirements of a specialist breast unit [J].

Blamey, R ;

Blichert-Toft, M ;

Cataliotti, L ;

Costa, A ;

Greco, M ;

Holland, R ;

Kaufmann, M ;

Perry, N ;

Ponti, A ;

Redmond, K ;

Sainsbury, R ;

van de Velde, C ;

Christiaens, M ;

Jassem, J ;

Julien, JP ;

Paridaens, R ;

Rutgers, E ;

van Limbergen, EF ;

Van den Bogaert, W ;

Vergote, I ;

Wildiers, J .

EUROPEAN JOURNAL OF CANCER, 2000, 36 (18) :2288-2293

[5]

Reading the prognosis of the individual with breast cancer [J].

Blamey, R. W. ;

Pinder, S. E. ;

Ball, G. R. ;

Ellis, I. O. ;

Elston, C. W. ;

Mitchell, M. J. ;

Haybittle, J. L. .

EUROPEAN JOURNAL OF CANCER, 2007, 43 (10) :1545-1547

[6]

Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole [J].

Bundred, Nigel J. ;

Campbell, Ian D. ;

Davidson, Neville ;

DeBoer, Richard H. ;

Eidtmann, Holger ;

Monnier, Alain ;

Neven, Patrick ;

von Minckwitz, Gunter ;

Miller, Joel C. ;

Schenk, Nora L. ;

Coleman, Robert E. .

CANCER, 2008, 112 (05) :1001-1010

[7]

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial [J].

Coombes, R. C. ;

Kilburn, L. S. ;

Snowdon, C. F. ;

Paridaens, R. ;

Coleman, R. E. ;

Jones, S. E. ;

Jassem, J. ;

Van de Velde, C. J. H. ;

Delozier, T. ;

Alvarez, I. ;

Del Mastro, L. ;

Ortmann, O. ;

Diedrich, K. ;

Coates, A. S. ;

Bajetta, E. ;

Holmberg, S. B. ;

Dodwell, D. ;

Mickiewicz, E. ;

Andersen, J. ;

Lonning, P. E. ;

Cocconi, G. ;

Forbes, J. ;

Castiglione, M. ;

Stuart, N. ;

Stewart, A. ;

Fallowfield, L. J. ;

Bertelli, G. ;

Hall, E. ;

Bogle, R. G. ;

Carpentieri, M. ;

Colajori, E. ;

Subar, M. ;

Ireland, E. ;

Bliss, J. M. .

LANCET, 2007, 369 (9561) :559-570

[8]

Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer [J].

Gianni, Luca ;

Baselga, Jose ;

Eiermann, Wolfgang ;

Porta, Vincente Guillem ;

Semiglazov, Vladimir ;

Lluch, Ana ;

Zambetti, Milvia ;

Sabadell, Dolores ;

Raab, Guenther ;

Cussac, Antonio Llombart ;

Bozhok, Alla ;

Martinez-Agullo, Angel ;

Greco, Marco ;

Byakhov, Mikhail ;

Lopez, Juan Jose Lopez ;

Mansutti, Mauro ;

Valagussa, Pinuccia ;

Bonadonna, Gianni .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) :2474-2481

[9]

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer [J].

Gnant, Michael ;

Mlineritsch, Brigitte ;

Schippinger, Walter ;

Luschin-Ebengreuth, Gero ;

Poestlberger, Sabine ;

Menzel, Christian ;

Jakesz, Raimund ;

Seifert, Michael ;

Hubalek, Michael ;

Bjelic-Radisic, Vesna ;

Samonigg, Hellmut ;

Tausch, Christoph ;

Eidtmann, Holger ;

Steger, Guenther ;

Kwasny, Werner ;

Dubsky, Peter ;

Fridrik, Michael ;

Fitzal, Florian ;

Stierer, Michael ;

Rucklinger, Ernst ;

Greil, Richard .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (07) :679-691

[10]

Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: A report from the Austrian Breast and Colorectal Cancer Study Group [J].

Gnant, Michael F. X. ;

Mlineritsch, Brigitte ;

Luschin-Ebengreuth, Gero ;

Grampp, Stephan ;

Kaessmann, Helmut ;

Schmid, Marianne ;

Menzel, Christian ;

Piswanger-Soelkner, Jutta Claudia ;

Galid, Arik ;

Mittlboeck, Martina ;

Hausmaninger, Hubert ;

Jakesz, Raimund .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) :820-828

← 1 2 3 →